Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC.
Paolo BorghettiJessica ImbresciaGiulia VolpiVieri ScottiMichele AquilanoAlessio BruniDavide FranceschiniStefano UrsinoPatrizia CiammellaGaia PipernoMaria TaraborrelliStefano Maria MagriniPublished in: Radiation oncology (London, England) (2022)
In this article, we propose a treatment strategy that might prolong post recurrence survival in patients with good performance status experiencing loco-regional relapse after surgery.